Skip to main content

Day: April 24, 2025

SUNation Energy Restructures $5.5 Million of Long-Term Debt, Improving Cash Flows and Enhancing Liquidity

RONKONKOMA, N.Y., April 24, 2025 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that it has amended the terms of a $5,486,000 Long Term Promissory Note (the “Note”) associated with the Company’s second acquisition dating from November 2022. Under the new terms of the Long-Term Note, as disclosed in our recent annual report on Form 10-K, the principal amount of the Note, previously due and payable as a one-time payment due in November 2025, together with all accrued and unpaid interest, has been extended and is to now due and payable in 36 monthly installments beginning in June 2025 through May 1, 2028. “The restructuring of this Note is the latest in a series of restructuring and debt...

Continue reading

Surebet Definitively Proven To Be Part of a Large-Scale Tier-1 Reduced Intrusion Related Gold System With Tremendous Upside Remaining, Golden Triangle, B.C.

Highlights Of The Geological Study Completed By The Colorado School Of Mines:A detailed geological study was recently completed by the Colorado School of Mines utilizing a compilation of drill holes and geological data. Conclusions of the geological study confirms a new interpretation of the ore forming process of high-grade gold mineralization at Surebet and confirms common causative Reduced Intrusion Related Gold (RIRG) source with tremendous untapped discovery potential.High-grade gold mineralization at Surebet occurs in two different settings, both containing visible gold in remarkably high percentages of the drill hole intersections. Of particular note is that the visible gold is fine to coarse grained, and includes up to abundant visible gold, with an increase of coarseness and abundance in vertical distribution. Which is consistent...

Continue reading

Purebase Corporation Expands Global Reach with Second International Shipment of Humate Advantage to India

Ione, CA, April 24, 2025 (GLOBE NEWSWIRE) — Purebase Corporation (OTCQB: PUBC), a leading provider of sustainable mineral-based solutions for agriculture and construction, is pleased to announce its second international shipment of Humate Advantage, this time to India. Following the recent dispatch to Pakistan, this marks another key milestone in the global distribution of the product, reinforcing Purebase’s growing international footprint. Humate Advantage is an organic soil amendment derived from natural mineral deposits developed to improve soil structure, enhance nutrient retention, and promote healthier, more resilient crop growth. With increasing global awareness of sustainable farming practices, Purebase is responding to demand from agricultural markets seeking long-term soil health solutions. These efforts aim to validate...

Continue reading

Progress Congratulates Chairman Jack Egan on NACD New England Leadership in Corporate Governance Award

Prestigious honor recognizes Egan’s outstanding contributions to corporate governance and board leadership BURLINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced that its Board Chair, John R. “Jack” Egan, has been honored with the Leadership in Corporate Governance Award by the National Association of Corporate Directors New England Chapter (NACDNE). This distinguished recognition highlights Egan’s exceptional leadership, dedication to corporate governance excellence and commitment to fostering strong, responsible board practices. A highly respected leader in the business and investment community, Egan is the founding managing partner of Egan-Managed Capital, L.P., a Boston-based venture capital...

Continue reading

CORRECTION: Boralex will release its 2025 first quarter financial results on May 14, at 9 a.m.

MONTREAL, April 24, 2025 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 first quarter results will take place on Wednesday, May 14, 2025, at 9 a.m. (previously announced at 9:30 a.m.). Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Wednesday, May 14, 2025, at 9 a.m. ET To attend the conference Webcast link: https://edge.media-server.com/mmc/p/3nwdfvm2  To attend the event by phone: Click here to register for the earnings call. Once you have completed your registration, you will receive a confirmation email containing the link and your personal PIN to connect to the call. If you lose this link and your PIN, you will be able to register again. You must register if you wish to...

Continue reading

Nexxen Advances AI Capabilities, Launches ‘nexAI’ 

Open and holistic approach to data is amplified by AI, more deeply connecting proprietary assets across Nexxen’s unified platform  The first of many advancements, a natively-integrated DSP assistant, prioritizes transparency and user control  NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) — Nexxen (NASDAQ: NEXN), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the launch of nexAI, a comprehensive suite of artificial intelligence (“AI”)-powered assistants and features, vertically integrated across the core pillars of its end-to-end platform. Fundamentally elevating every stage of the advertising life cycle, nexAI takes a transparent approach to planning and activation as well as optimization and monetization, continuously iterating and improving to deliver greater efficiency....

Continue reading

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that its proprietary Gen-2 neurostimulation device has received institutional review board (IRB) approval in Brazil for a new clinical trial evaluating its use in the treatment of anxiety disorders and chronic insomnia. The study will be conducted at the Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IPq-HCFMUSP), one of Latin America’s most prestigious psychiatric research institutions. The first Nexalin device has been shipped to São Paulo, Brazil, with additional units and single-use disposable electrodes scheduled for delivery in the coming days. These...

Continue reading

Hanmi Financial Declares Cash Dividend of $0.27 per share

LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors declared a cash dividend on its common stock for the 2025 second quarter of $0.27 per share. The dividend will be paid on May 21, 2025, to stockholders of record as of the close of business on May 5, 2025. About Hanmi Financial Corporation Headquartered in Los Angeles, California, Hanmi Financial Corporation owns Hanmi Bank, which serves multi-ethnic communities through its network of 32 full-service branches, five loan production offices and three loan centers in California, Texas, Illinois, Virginia, New Jersey, New York, Colorado, Washington and Georgia. Hanmi Bank specializes in real estate, commercial, SBA and trade finance lending...

Continue reading

West Bancorporation, Inc. Announces First Quarter 2025 Financial Results and Declares Quarterly Dividend

WEST DES MOINES, Iowa, April 24, 2025 (GLOBE NEWSWIRE) — West Bancorporation, Inc. (Nasdaq: WTBA; the “Company”), parent company of West Bank, today reported first quarter 2025 net income of $7.8 million, or $0.46 per diluted common share, compared to fourth quarter 2024 net income of $7.1 million, or $0.42 per diluted common share, and first quarter 2024 net income of $5.8 million, or $0.35 per diluted common share. On April 23, 2025, the Company’s Board of Directors declared a regular quarterly dividend of $0.25 per common share. The dividend is payable on May 21, 2025, to stockholders of record on May 7, 2025. David Nelson, President and Chief Executive Officer of the Company, commented, “In the first quarter of 2025, we have continued to see improvements in net interest margin and efficiency ratio compared to 2024, resulting...

Continue reading

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2025 will be released before markets open on Thursday, May 8th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, May 8th to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 63341. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.